Natrunix or Placebo in Combination With Methotrexate in Rheumatoid Arthritis
Status:
Not yet recruiting
Trial end date:
2023-02-15
Target enrollment:
Participant gender:
Summary
Phase II, Double-Blind, Placebo-Controlled, Randomized Trial Examining Natrunix in
Combination with MTX (+Folate) for the Treatment of Rheumatoid Arthritis